Search for Clinical Trial Results

Sponsored By

Nasopharyngeal Neoplasms - 21 Studies Found

Status Study
Completed Study Name: ADjuVant Apatinib in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy
Condition: Nasopharyngeal Neoplasms
Date: 2016-08-01
Interventions:
  • Drug: Apatinib Patients will t
Completed Study Name: Clinical Target Volume Based on Disease Extension Risk Atlas and Computer-aided Delineation in Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2015-12-03
Interventions:
  • Radiation: IMRT using individualized CTV

Completed Study Name: The Value of Diagnosis and Outcome Prediction in CTC for Metastatic NPC Patients
Condition: Nasopharyngeal Neoplasms
Date: 2015-07-20
Interventions: Other: the number of circulating tumor cells
Completed Study Name: Combination of Docetaxel, Cisplatin, and Capecitabine (DCX) in the Treatment of Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2015-02-03
Interventions:
  • Drug: Docetaxel 75mg/㎡,
Active, not recruiting Study Name: Safety and Efficacy of Oral Azacitidine in Previously Treated Subjects With Locally Advanced or Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2014-10-17
Interventions: Drug: CC-486 Other Name: oral azacitidine
Completed Study Name: Efficacy and Safety of TC+AVASTIN Versus TC in Patients With Metastatic Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2014-08-26
Interventions:
  • Drug: Paclitaxel Paclitaxel 17
Completed Study Name: Dose-finding Study of Abraxane in Combination With Cisplatin to Treat Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2012-11-22
Interventions:
  • Drug: ABX + DDP ABX 260 mg/m2

Active, not recruiting Study Name: Effect and Safety Study of GP/FP Regimens in Advanced Nasopharyngeal Carcinoma
Condition: Nasopharyngeal Neoplasms
Date: 2012-01-31
Interventions:
  • Drug: gemcitabine and cisplatin

Completed Study Name: Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer
Condition: Nasopharyngeal Neoplasms
Date: 2004-02-27
Interventions: Drug: EBV-LMP-2
Completed Study Name: Environmental and Genetic Determinants of NPC
Condition:
  • Nasopharyngeal Neoplasms
  • Herpesvirus 4, Human

Date: 2010-12-08
<<< Previous | Next >>>